Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...

And here’s what else you need to know to Start Your Week Smart . Your day is busy. 5 Things is your one-stop shop for the ...

The FDA approved Eli Lilly's Zepbound as the first drug for obesity-linked moderate-to-severe sleep apnea, potentially transforming treatment options for 80 million Americans.

The new approval means that insurance providers will likely cover the medication for people with sleep apnea and obesity.

The FDA has granted approval for its first medication for certain patients with sleep apnea—the weight-loss drug Zepbound.

There are many breakthroughs in medicine regarding the treatment of obstructive sleep apnea, and a weight loss drug might ...

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

Protein powder is one such supplement which has become increasingly popular over recent years, with many users who want to achieve weight loss and muscle growth. This editorial reviews the impact ...

There are a few different types of sleep apnea: obstructive, central and mixed ... especially if that weight sits in the neck or chest area. Dzierzewski said that men tend to display higher ...